INTRAMUSCULAR ADMINISTRATION OF HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN RABBITS AND DOGS AND ITS IMPLICATIONS FOR CORONARY THROMBOLYSIS

被引:13
作者
SOBEL, BE
SAFFITZ, JE
FIELDS, LE
MYEARS, DW
SARNOFF, SJ
ROBISON, AK
OWENSBY, DA
FOX, KAA
机构
关键词
D O I
10.1161/01.CIR.75.6.1261
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1261 / 1272
页数:12
相关论文
共 18 条
[1]  
ANGELESCANO E, 1986, ANAL BIOCHEM, V153, P201
[2]   TEMPORAL DEPENDENCE OF BENEFICIAL-EFFECTS OF CORONARY THROMBOLYSIS CHARACTERIZED BY POSITRON TOMOGRAPHY [J].
BERGMANN, SR ;
LERCH, RA ;
FOX, KAA ;
LUDBROOK, PA ;
WELCH, MJ ;
TERPOGOSSIAN, MM ;
SOBEL, BE .
AMERICAN JOURNAL OF MEDICINE, 1982, 73 (04) :573-581
[3]  
BERGMANN SR, 1983, SCIENCE, V220, P1181
[4]   SYSTEMIC THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL-INFARCTION [J].
COLLEN, D ;
VERSTRAETE, M .
CIRCULATION, 1983, 68 (02) :462-465
[5]  
DEVRIES S R, 1987, Fibrinolysis, V1, P17, DOI 10.1016/0268-9499(87)90027-0
[6]   PREVENTION OF CORONARY-THROMBOSIS WITH SUBTHROMBOLYTIC DOSES OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].
FOX, KAA ;
ROBISON, AK ;
KNABB, RM ;
ROSAMOND, TL ;
SOBEL, BE ;
BERGMANN, SR .
CIRCULATION, 1985, 72 (06) :1346-1354
[7]   ACUTE CORONARY REOCCLUSION AFTER THROMBOLYSIS WITH RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR - PREVENTION BY A MAINTENANCE INFUSION [J].
GOLD, HK ;
LEINBACH, RC ;
GARABEDIAN, HD ;
YASUDA, T ;
JOHNS, JA ;
GROSSBARD, EB ;
PALACIOS, I ;
COLLEN, D .
CIRCULATION, 1986, 73 (02) :347-352
[8]   TISSUE DIFFERENCES IN VASCULAR-PERMEABILITY CHANGES INDUCED BY HISTAMINE [J].
KILZER, P ;
CHANG, K ;
MARVEL, J ;
KILO, C ;
WILLIAMSON, JR .
MICROVASCULAR RESEARCH, 1985, 30 (03) :270-285
[9]   TIME FROM ONSET OF SYMPTOMS TO THROMBOLYTIC THERAPY - A MAJOR DETERMINANT OF MYOCARDIAL SALVAGE IN PATIENTS WITH ACUTE TRANSMURAL INFARCTION [J].
MATHEY, DG ;
SHEEHAN, FH ;
SCHOFER, J ;
DODGE, HT .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 6 (03) :518-525
[10]  
SIMOONS ML, 1985, LANCET, V2, P578